Roles and Mechanisms of β-Thymosins in Cell Migration and Cancer Metastasis: An Update

REFERENCES

• Carlier MF, Didry D, Erk I, Lepault J, Van Troys ML, Vandekerckhove J, Perelroizen I, Yin H, Doi Y, Pantaloni D. Tβ4 is not a simple G-actin sequestering protein and interacts with F-actin at high concentration. J Biol Chem 1996;271(16):9231–9239.
   PubMed Web of Science ®Google Scholar
• Dedova IV, Nikolaeva OP, Safer D, De La Cruz EM, dos Remedios CG. Thymosin β4 induces a conformational change in actin monomers. Biophys J 2006;90(3):985–992.
   PubMed Web of Science ®Google Scholar
• Yarmola EG, Klimenko ES, Fujita G, Bubb MR. Thymosin β4: actin regulation and more. Ann NY Acad Sci 2007;1112:76–85.
   PubMed Web of Science ®Google Scholar
• Grant DS, Kinsella JL, Kibbey MC, LaFlamme S, Burbelo PD, Goldstein AL, Kleinman HK. Matrigel induces thymosin β4 gene in differentiating endothelial cells. J Cell Sci 1995;108(Pt 12):3685–3694.
   PubMedGoogle Scholar
• Grant DS, Rose W, Yaen C, Goldstein A, Martinez J, Kleinman H. Thymosin β4 enhances endothelial cell differentiation and angiogenesis. Angiogenesis 1999;3(2):125–135.
   PubMedGoogle Scholar
• Malinda KM, Goldstein AL, Kleinman HK. Thymosin β4 stimulates directional migration of human umbilical vein endothelial cells. FASEB J 1997;11(6):474–481.
   PubMed Web of Science ®Google Scholar
• Kraehenbuehl TP, Ferreira LS, Zammaretti P, Hubbell JA, Langer R. Cell-responsive hydrogel for encapsulation of vascular cells. Biomaterials 2009;30(26):4318–4324.
   PubMed Web of Science ®Google Scholar
• Chiu LL, Radisic M. Controlled release of thymosin β4 using collagen-chitosan composite hydrogels promotes epicardial cell migration and angiogenesis. J Control Release 2011;155(3):376–385.
   PubMed Web of Science ®Google Scholar
• Oh IS, So SS, Jahng KY, Kim HG. Hepatocyte growth factor upregulates thymosin β4 in human umbilical vein endothelial cells. Biochem Biophys Res Commun 2002;296(2):401–405.
   PubMed Web of Science ®Google Scholar
• Philp D, Huff T, Gho YS, Hannappel E, Kleinman HK. The actin binding site on thymosin β4 promotes angiogenesis. FASEB J 2003;17(14):2103–2105.
   PubMedGoogle Scholar
• Cierniewski CS, Malinowski M, Bednarek R, Cierniewska-Cieslak A. Adhesive and proteolytic phenotype of migrating endothelial cells induced by thymosin β4. Ann NY Acad Sci 2007;1112:123–139.
   PubMed Web of Science ®Google Scholar
• Philp D, Scheremeta B, Sibliss K, Zhou M, Fine EL, Nguyen M, Wahl L, Hoffman MP, Kleinman HK. Thymosin β4 promotes matrix metalloproteinase expression during wound repair. J Cell Physiol 2006;208(1):195–200.
   PubMed Web of Science ®Google Scholar
• Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D. Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 2004;432(7016):466–472.
   PubMed Web of Science ®Google Scholar
• Fan Y, Gong Y, Ghosh PK, Graham LM, Fox PL. Spatial coordination of actin polymerization and ILK-Akt2 activity during endothelial cell migration. Dev Cell 2009;16(5):661–674.
   PubMed Web of Science ®Google Scholar
• Freeman KW, Bowman BR, Zetter BR. Regenerative protein thymosin β4 is a novel regulator of purinergic signaling. FASEB J 2011;25(3):907–915.
   PubMed Web of Science ®Google Scholar
• Selmi A, Malinowski M, Brutkowski W, Bednarek R, Cierniewski CS. Thymosin β4 promotes the migration of endothelial cells without intracellular Ca2+ elevation. Exp Cell Res 2012;318(14):1659–666.
   PubMed Web of Science ®Google Scholar
• Qiu FY, Song XX, Zheng H, Zhao YB, Fu GS. Thymosin β4 induces endothelial progenitor cell migration via PI3K/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol 2009;53(3):209–214.
   PubMed Web of Science ®Google Scholar
• Kupatt C, Bock-Marquette I, Boekstegers P. Embryonic endothelial progenitor cell-mediated cardioprotection requires Thymosin β4. Trends Cardiovasc Med 2008;18(6):205–210.
   PubMed Web of Science ®Google Scholar
• Hinkel R, El-Aouni C, Olson T, Horstkotte J, Mayer S, Muller S, Willhauck M, Spitzweg C, Gildehaus FJ, Munzing W, Hannappel E, Bock-Marquette I, DiMaio JM, Hatzopoulos AK, Boekstegers P, Kupatt C. Thymosin β4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection. Circulation 2008;117(17):2232–2240.
   PubMed Web of Science ®Google Scholar
• Bock-Marquette I, Shrivastava S, Pipes GC, Thatcher JE, Blystone A, Shelton JM, Galindo CL, Melegh B, Srivastava D, Olson EN, DiMaio JM. Thymosin β4 mediated PKC activation is essential to initiate the embryonic coronary developmental program and epicardial progenitor cell activation in adult mice in vivo. J Mol Cell Cardiol 2009;46(5):728–738.
   PubMed Web of Science ®Google Scholar
• Lee SH, Son MJ, Oh SH, Rho SB, Park K, Kim YJ, Park MS, Lee JH. Thymosin β10 inhibits angiogenesis and tumor growth by interfering with Ras function. Cancer Res 2005;65(1):137–148.
   PubMed Web of Science ®Google Scholar
• Mu H, Ohashi R, Yang H, Wang X, Li M, Lin P, Yao Q, Chen C. Thymosin β10 inhibits cell migration and capillary-like tube formation of human coronary artery endothelial cells. Cell Motil Cytoskeleton 2006;63(4):222–230.
   PubMed Web of Science ®Google Scholar
• Zhang T, Li X, Yu W, Yan Z, Zou H, He X. Overexpression of thymosin β10 inhibits VEGF mRNA expression, autocrine VEGF protein production, and tube formation in hypoxia-induced monkey choroid-retinal endothelial cells. Ophthalmic Res 2009;41(1):36–43.
   PubMed Web of Science ®Google Scholar
• Qian L, Huang Y, Spencer CI, Foley A, Vedantham V, Liu L, Conway SJ, Fu JD, Srivastava D. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012;485(7400):593–598.
   PubMed Web of Science ®Google Scholar
• Yesilay AB, Karakurt O, Akdemir R, Erden G, Kilic H, Acikel S, Karasu B, Sari M, Balci M, Aksoy M. Thymosin β4 levels after successful primary percutaneous coronary intervention for acute myocardial infarction. Turk Kardiyol Dern Ars 2011;39(8):654–660.
   PubMedGoogle Scholar
• Smart N, Risebro CA, Melville AA, Moses K, Schwartz RJ, Chien KR, Riley PR. Thymosin β4 induces adult epicardial progenitor mobilization and neovascularization. Nature 2007;445(7124):177–182.
   PubMed Web of Science ®Google Scholar
• Smart N, Risebro CA, Melville AA, Moses K, Schwartz RJ, Chien KR, Riley PR. Thymosin β4 is essential for coronary vessel development and promotes neovascularization via adult epicardium. Ann NY Acad Sci 2007;1112:171–188.
   PubMed Web of Science ®Google Scholar
• Banerjee I, Zhang J, Moore-Morris T, Lange S, Shen T, Dalton ND, Gu Y, Peterson KL, Evans SM, Chen J. Thymosin β4 is dispensable for murine cardiac development and function. Circ Res 2012;110(3):456–464.
   PubMed Web of Science ®Google Scholar
• Gajzer DC, Balbin J, Chaudhry HW. Thymosin β4 and cardiac Regeneration: Are we missing a beat? Stem Cell Rev 2012, doi: 10.1007/s12015-012-9378-3.
   Web of Science ®Google Scholar
• Smart N, Hill AA, Cross JC, Riley PR. A differential screen for putative targets of the bHLH transcription factor Hand1 in cardiac morphogenesis. Mech Dev 2002; 119(Suppl 1):S65–S71.
   PubMedGoogle Scholar
• Smart N, Dube KN, Riley PR. Identification of Thymosin β4 as an effector of Hand1-mediated vascular development. Nat Commun 2010;1:46.
   PubMed Web of Science ®Google Scholar
• Shrivastava S, Srivastava D, Olson EN, DiMaio JM, Bock-Marquette I. Thymosin β4 and cardiac repair. Ann NY Acad Sci 2010;1194:87–96.
   PubMed Web of Science ®Google Scholar
• Roth LW, Bormann P, Wiederkehr C, Reinhard E. β-thymosin, a modulator of the actin cytoskeleton is increased in regenerating retinal ganglion cells. Eur J Neurosci 1999;11(10):3488–3498.
   PubMed Web of Science ®Google Scholar
• Roth LW, Bormann P, Bonnet A, Reinhard E. β-thymosin is required for axonal tract formation in developing zebrafish brain. Development 1999;126(7):1365–1374.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Mahmood A, Meng Y, Zhang Y, Zhang ZG, Morris DC, Chopp M. Treatment of traumatic brain injury with thymosin β4 in rats. J Neurosurg 2011;114(1):102–115.
   PubMed Web of Science ®Google Scholar
• Xiong Y, Zhang Y, Mahmood A, Meng Y, Zhang ZG, Morris DC, Chopp M. Neuroprotective and neurorestorative effects of thymosin β4 treatment initiated 6 hours after traumatic brain injury in rats. J Neurosurg 2012;116(5):1081–1092.
   PubMed Web of Science ®Google Scholar
• Border BG, Lin SC, Griffin WS, Pardue S, Morrison-Bogorad M. Alterations in actin-binding β-thymosin expression accompany neuronal differentiation and migration in rat cerebellum. J Neurochem 1993;61(6):2104–2114.
   PubMed Web of Science ®Google Scholar
• Choe J, Sun W, Yoon SY, Rhyu IJ, Kim EH, Kim H. Effect of thymosin β15 on the branching of developing neurons. Biochem Biophys Res Commun 2005;331(1):43–49.
   PubMed Web of Science ®Google Scholar
• Yang H, Cheng X, Yao Q, Li J, Ju G. The promotive effects of thymosin β4 on neuronal survival and neurite outgrowth by upregulating L1 expression. Neurochem Res 2008;33(11):2269–2280.
   PubMed Web of Science ®Google Scholar
• Mollinari C, Ricci-Vitiani L, Pieri M, Lucantoni C, Rinaldi AM, Racaniello M, De Maria R, Zona C, Pallini R, Merlo D, Garaci E. Downregulation of thymosin β4 in neural progenitor grafts promotes spinal cord regeneration. J Cell Sci 2009;122(Pt 22):4195–4207.
   PubMed Web of Science ®Google Scholar
• van Kesteren RE, Carter C, Dissel HM, van Minnen J, Gouwenberg Y, Syed NI, Spencer GE, Smit AB. Local synthesis of actin-binding protein β-thymosin regulates neurite outgrowth. J Neurosci 2006;26(1):152–157.
   PubMed Web of Science ®Google Scholar
• Golla R, Philp N, Safer D, Chintapalli J, Hoffman R, Collins L, Nachmias VT. Co-ordinate regulation of the cytoskeleton in 3T3 cells overexpressing thymosin-β4. Cell Motil Cytoskeleton 1997;38(2):187–200.
   PubMed Web of Science ®Google Scholar
• Philp D, Kleinman HK. Animal studies with thymosin β, a multifunctional tissue repair and regeneration peptide. Ann NY Acad Sci 2010;1194:81–86.
   PubMed Web of Science ®Google Scholar
• Li X, Zheng L, Peng F, Qi C, Zhang X, Zhou A, Liu Z, Wu S. Recombinant thymosin β4 can promote full-thickness cutaneous wound healing. Protein Expr Purif 2007;56(2):229–236.
   PubMed Web of Science ®Google Scholar
• Malinda KM, Sidhu GS, Mani H, Banaudha K, Maheshwari RK, Goldstein AL, Kleinman HK. Thymosin β4 accelerates wound healing. J Invest Dermatol 1999;113(3):364–368.
   PubMed Web of Science ®Google Scholar
• Goldstein AL, Hannappel E, Kleinman HK. Thymosin β4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med 2005;11(9):421–429.
   PubMed Web of Science ®Google Scholar
• Francis Godschalk M. Pressure ulcers: a role for thymosin β4. Ann NY Acad Sci 2007;1112:413–417.
   PubMed Web of Science ®Google Scholar
• Guarnera G, DE Rosa A, Camerini R. Thymosin β4 and venous ulcers: clinical remarks on a European prospective, randomized study on safety, tolerability, and enhancement on healing. Ann NY Acad Sci 2007;1112:407–412.
   PubMed Web of Science ®Google Scholar
• Treadwell T, Kleinman HK, Crockford D, Hardy MA, Guarnera GT, Goldstein AL. The regenerative peptide thymosin β4 accelerates the rate of dermal healing in preclinical animal models and in patients. Ann NY Acad Sci 2012;1270:37–44.
   PubMed Web of Science ®Google Scholar
• Philp D, Badamchian M, Scheremeta B, Nguyen M, Goldstein AL, Kleinman HK. Thymosin β4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice. Wound Repair Regen 2003;11(1):19–24.
   PubMed Web of Science ®Google Scholar
• Ehrlich HP, Hazard SW, 3rd. Thymosin β4 enhances repair by organizing connective tissue and preventing the appearance of myofibroblasts. Ann NY Acad Sci 2010;1194:118–124.
   PubMed Web of Science ®Google Scholar
• Huang CM, Wang CC, Barnes S, Elmets CA. In vivo detection of secreted proteins from wounded skin using capillary ultrafiltration probes and mass spectrometric proteomics. Proteomics 2006;6(21):5805–5814.
   PubMed Web of Science ®Google Scholar
• Philp D, Goldstein AL, Kleinman HK. Thymosin β4 promotes angiogenesis, wound healing, and hair follicle development. Mech Ageing Dev 2004;125(2):113–115.
   PubMed Web of Science ®Google Scholar
• Philp D, Nguyen M, Scheremeta B, St-Surin S, Villa AM, Orgel A, Kleinman HK, Elkin M. Thymosin β4 increases hair growth by activation of hair follicle stem cells. FASEB J 2004;18(2):385–387.
   PubMedGoogle Scholar
• Philp D, St-Surin S, Cha HJ, Moon HS, Kleinman HK, Elkin M. Thymosin β4 induces hair growth via stem cell migration and differentiation. Ann NY Acad Sci 2007;1112:95–103.
   PubMed Web of Science ®Google Scholar
• Sosne G, Chan CC, Thai K, Kennedy M, Szliter EA, Hazlett LD, Kleinman HK. Thymosin β4 promotes corneal wound healing and modulates inflammatory mediators in vivo. Exp Eye Res 2001;72(5):605–608.
   PubMed Web of Science ®Google Scholar
• Sosne G, Szliter EA, Barrett R, Kernacki KA, Kleinman H, Hazlett LD. Thymosin β4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury. Exp Eye Res 2002;74(2):293–299.
   PubMed Web of Science ®Google Scholar
• Sosne G, Siddiqi A, Kurpakus-Wheater M. Thymosin-β4 inhibits corneal epithelial cell apoptosis after ethanol exposure in vitro. Invest Ophthalmol Vis Sci 2004;45(4):1095–1100.
   PubMed Web of Science ®Google Scholar
• Sosne G, Qiu P, Kurpakus-Wheater M. Thymosin β4 and the eye: I can see clearly now the pain is gone. Ann NY Acad Sci 2007;1112:114–122.
   PubMed Web of Science ®Google Scholar
• Sosne G, Qiu P, Kurpakus-Wheater M. Thymosin β4: A novel corneal wound healing and anti-inflammatory agent. Clin Ophthalmol 2007;1(3):201–207.
   PubMedGoogle Scholar
• Sosne G, Qiu P, Kurpakus-Wheater M, Matthew H. Thymosin β4 and corneal wound healing: visions of the future. Ann NY Acad Sci 2010;1194:190–198.
   PubMed Web of Science ®Google Scholar
• Dunn SP, Heidemann DG, Chow CY, Crockford D, Turjman N, Angel J, Allan CB, Sosne G. Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin β4. Ann NY Acad Sci 2010;1194:199–206.
   PubMed Web of Science ®Google Scholar
• Sosne G, Hafeez S, Greenberry AL, 2nd, Kurpakus-Wheater M. Thymosin β4 promotes human conjunctival epithelial cell migration. Curr Eye Res 2002;24(4):268–273.
   PubMed Web of Science ®Google Scholar
• Sosne G, Xu L, Prach L, Mrock LK, Kleinman HK, Letterio JJ, Hazlett LD, Kurpakus-Wheater M. Thymosin β4 stimulates laminin-5 production independent of TGF-b. Exp Cell Res 2004;293(1):175–183.
   PubMed Web of Science ®Google Scholar
• Qiu P, Kurpakus-Wheater M, Sosne G. Matrix metalloproteinase activity is necessary for thymosin β4 promotion of epithelial cell migration. J Cell Physiol 2007;212(1):165–173.
   PubMed Web of Science ®Google Scholar
• Roy P, Rajfur Z, Jones D, Marriott G, Loew L, Jacobson K. Local photorelease of caged thymosin β4 in locomoting keratocytes causes cell turning. J Cell Biol 2001;153(5):1035–1048.
   PubMed Web of Science ®Google Scholar
• Wang WS, Chen PM, Hsiao HL, Ju SY, Su Y. Overexpression of the thymosin β4 gene is associated with malignant progression of SW480 colon cancer cells. Oncogene 2003;22(21): 3297–3306.
   PubMed Web of Science ®Google Scholar
• Wang WS, Chen PM, Hsiao HL, Wang HS, Liang WY, Su Y. Overexpression of the thymosin β4 gene is associated with increased invasion of SW480 colon carcinoma cells and the distant metastasis of human colorectal carcinoma. Oncogene 2004;23(39):6666–6671.
   PubMed Web of Science ®Google Scholar
• Jain AK, Moore SM, Yamaguchi K, Eling TE, Baek SJ. Selective nonsteroidal anti-inflammatory drugs induce thymosin β4 and alter actin cytoskeletal organization in human colorectal cancer cells. J Pharmacol Exp Ther 2004;311(3):885–891.
   PubMed Web of Science ®Google Scholar
• Huang HC, Hu CH, Tang MC, Wang WS, Chen PM, Su Y. Thymosin β4 triggers an epithelial-mesenchymal transition in colorectal carcinoma by upregulating integrin-linked kinase. Oncogene 2007;26(19):2781–290.
   PubMed Web of Science ®Google Scholar
• Tang MC, Chan LC, Yeh YC, Chen CY, Chou TY, Wang WS, Su Y. Thymosin β4 induces colon cancer cell migration and clinical metastasis via enhancing ILK/IQGAP1/Rac1 signal transduction pathway. Cancer Lett 2011;308(2):162–171.
   PubMed Web of Science ®Google Scholar
• Ricci-Vitiani L, Mollinari C, di Martino S, Biffoni M, Pilozzi E, Pagliuca A, de Stefano MC, Circo R, Merlo D, De Maria R, Garaci E. Thymosin β4 targeting impairs tumorigenic activity of colon cancer stem cells. FASEB J 2010;24(11):4291–4301.
   PubMed Web of Science ®Google Scholar
• Hsiao HL, Wang WS, Chen PM, Su Y. Overexpression of thymosin β4 renders SW480 colon carcinoma cells more resistant to apoptosis triggered by FasL and two topoisomerase II inhibitors via downregulating Fas and upregulating Survivin expression, respectively. Carcinogenesis 2006;27(5):936–944.
   PubMed Web of Science ®Google Scholar
• Nemolato S, Restivo A, Cabras T, Coni P, Zorcolo L, Orru G, Fanari M, Cau F, Gerosa C, Fanni D, Messana I, Castagnola M, Casula G, Faa G. Thymosin β4 in colorectal cancer is localized predominantly at the invasion front in tumor cells undergoing epithelial mesenchymal transition. Cancer Biol Ther 2012;13(4):191–197.
   PubMed Web of Science ®Google Scholar
• Cierniewski CS, Papiewska-Pajak I, Malinowski M, Sacewicz-Hofman I, Wiktorska M, Kryczka J, Wysocki T, Niewiarowska J, Bednarek R. Thymosin β4 regulates migration of colon cancer cells by a pathway involving interaction with Ku80. Ann NY Acad Sci 2010;1194:60–71.
   PubMed Web of Science ®Google Scholar
• Ryu YK, Lee YS, Lee GH, Song KS, Kim YS, Moon EY. Regulation of glycogen synthase kinase-3 by thymosin β4 is associated with gastric cancer cell migration. Int J Cancer 2012;131(9):2067–2077.
   PubMed Web of Science ®Google Scholar
• Nummela P, Yin M, Kielosto M, Leaner V, Birrer MJ, Holtta E. Thymosin β4 is a determinant of the transformed phenotype and invasiveness of S-adenosylmethionine decarboxylase-transfected fibroblasts. Cancer Res 2006;66(2):701–712.
   PubMed Web of Science ®Google Scholar
• Cha HJ, Jeong MJ, Kleinman HK. Role of thymosin β4 in tumor metastasis and angiogenesis. J Natl Cancer Inst 2003;95(22):1674–1680.
   PubMed Web of Science ®Google Scholar
• Jo JO, Kim SR, Bae MK, Kang YJ, Ock MS, Kleinman HK, Cha HJ. Thymosin β4 induces the expression of vascular endothelial growth factor (VEGF) in a hypoxia-inducible factor (HIF)-1alpha-dependent manner. Biochim Biophys Acta 2010;1803(11):1244–1251.
   PubMed Web of Science ®Google Scholar
• Hardesty WM, Kelley MC, Mi D, Low RL, Caprioli RM. Protein signatures for survival and recurrence in metastatic melanoma. J Proteomics 2011;74(7):1002–1014.
   PubMed Web of Science ®Google Scholar
• Oh JM, Moon EY. Actin-sequestering protein, thymosin β4, induces paclitaxel resistance through ROS/HIF-1alpha stabilization in HeLa human cervical tumor cells. Life Sci 2010;87(9–10):286–293.
   PubMed Web of Science ®Google Scholar
• Moon EY, Im YS, Ryu YK, Kang JH. Actin-sequestering protein, thymosin β4, is a novel hypoxia responsive regulator. Clin Exp Metast 2010;27(8):601–609.
   PubMed Web of Science ®Google Scholar
• Ryu YK, Im YS, Moon EY. Cooperation of actin-sequestering protein, thymosin β4 and hypoxia inducible factor-1α in tumor cell migration. Oncol Rep 2010;24(5):1389–1394.
   PubMed Web of Science ®Google Scholar
• Kim A, Son M, Kim KI, Yang Y, Song EY, Lee HG, Lim JS. Elevation of intracellular cyclic AMP inhibits NF-κB-mediated thymosin β4 expression in melanoma cells. Exp Cell Res 2009;315(19):3325–3335.
   PubMed Web of Science ®Google Scholar
• Chiappetta G, Pentimalli F, Monaco M, Fedele M, Pasquinelli R, Pierantoni GM, Ribecco MT, Santelli G, Califano D, Pezzullo L, Fusco A. Thymosin β10 gene expression as a possible tool in diagnosis of thyroid neoplasias. Oncol Rep 2004;12(2): 239–243.
   PubMed Web of Science ®Google Scholar
• Feher LZ, Pocsay G, Krenacs L, Zvara A, Bagdi E, Pocsay R, Lukacs G, Gyory F, Gazdag A, Tarko E, Puskas LG. Amplification of thymosin β10 and AKAP13 genes in metastatic and aggressive papillary thyroid carcinomas. Pathol Oncol Res 2012;18(2):449–458.
   PubMed Web of Science ®Google Scholar
• Conlon JM, Grimelius L, Wallin G, Thim L. Isolation and structural characterization of thymosin-β4 from a human medullary thyroid carcinoma. J Endocrinol 1988;118(1):155–159.
   PubMed Web of Science ®Google Scholar
• Liu JM, Kusinski M, Ilic V, Bignon J, Hajem N, Komorowski J, Kuzdak K, Stepien H, Wdzieczak-Bakala J. Overexpression of the angiogenic tetrapeptide AcSDKP in human malignant tumors. Anticancer Res 2008;28(5A):2813–2817.
   PubMed Web of Science ®Google Scholar
• Califano D, Monaco C, Santelli G, Giuliano A, Veronese ML, Berlingieri MT, de Franciscis V, Berger N, Trapasso F, Santoro M, Viglietto G, Fusco A. Thymosin β10 gene overexpression correlated with the highly malignant neoplastic phenotype of transformed thyroid cells in vivo and in vitro. Cancer Res 1998;58(4):823–828.
   PubMed Web of Science ®Google Scholar
• Takano T, Hasegawa Y, Miyauchi A, Matsuzuka F, Yoshida H, Kuma K, Amino N. Quantitative analysis of thymosin β10 messenger RNA in thyroid carcinomas. Jpn J Clin Oncol 2002;32(7):229–232.
   PubMed Web of Science ®Google Scholar
• Santelli G, Bartoli PC, Giuliano A, Porcellini A, Mineo A, Barone MV, Busiello I, Trapasso F, Califano D, Fusco A. Thymosin β10 protein synthesis suppression reduces the growth of human thyroid carcinoma cells in semisolid medium. Thyroid 2002;12(9):765–772.
   PubMed Web of Science ®Google Scholar
• McDoniels-Silvers AL, Nimri CF, Stoner GD, Lubet RA, You M. Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin Cancer Res 2002;8(4):1127–1138.
   PubMed Web of Science ®Google Scholar
• Gu Y, Wang C, Wang Y, Qiu X, Wang E. Expression of thymosin β10 and its role in non-small cell lung cancer. Hum Pathol 2009;40(1):117–124.
   PubMed Web of Science ®Google Scholar
• Lee SM, Na YK, Hong HS, Jang EJ, Yoon GS, Park JY, Kim DS. Hypomethylation of the thymosin β10 gene is not associated with its overexpression in non-small cell lung cancer. Mol Cells 2011;32(4):343–348.
   PubMed Web of Science ®Google Scholar
• Bao L, Loda M, Zetter BR. Thymosin β15 expression in tumor cell lines with varying metastatic potential. Clin Exp Metast 1998;16(3):227–233.
   PubMed Web of Science ®Google Scholar
• Gu YM, Li SY, Qiu XS, Wang EH. Elevated thymosin β15 expression is associated with progression and metastasis of non-small cell lung cancer. APMIS 2008; 116(6):484–490.
   PubMed Web of Science ®Google Scholar
• Verghese-Nikolakaki S, Apostolikas N, Livaniou E, Ithakissios DS, Evangelatos GP. Preliminary findings on the expression of thymosin β10 in human breast cancer. Br J Cancer 1996;74(9):1441–1444.
   PubMed Web of Science ®Google Scholar
• Liu CR, Ma CS, Ning JY, You JF, Liao SL, Zheng J. Differential thymosin β10 expression levels and actin filament organization in tumor cell lines with different metastatic potential. Chin Med J 2004;117(2):213–218.
   PubMed Web of Science ®Google Scholar
• Maelan AE, Rasmussen TK, Larsson LI. Localization of thymosin β10 in breast cancer cells: relationship to actin cytoskeletal remodeling and cell motility. Histochem Cell Biol 2007;127(1):109–113.
   PubMed Web of Science ®Google Scholar
• Larsson LI, Holck S. Occurrence of thymosin β4 in human breast cancer cells and in other cell types of the tumor microenvironment. Hum Pathol 2007;38(1):114–119.
   PubMed Web of Science ®Google Scholar
• Gold JS, Bao L, Ghoussoub RA, Zetter BR, Rimm DL. Localization and quantitation of expression of the cell motility-related protein thymosin β15 in human breast tissue. Mod Pathol 1997;10(11):1106–1112.
   PubMed Web of Science ®Google Scholar
• Lee SH, Zhang W, Choi JJ, Cho YS, Oh SH, Kim JW, Hu L, Xu J, Liu J, Lee JH. Overexpression of the thymosin β10 gene in human ovarian cancer cells disrupts F-actin stress fiber and leads to apoptosis. Oncogene 2001;20(46):6700–6706.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Gotoh M, Kitajima M, Hirohashi S. Thymosin β4 expression is correlated with metastatic capacity of colorectal carcinomas. Biochem Biophys Res Commun 1993;193(2):706–710.
   PubMed Web of Science ®Google Scholar
• Kim NS, Kang YJ, Jo JO, Kim HY, Oh YR, Kim YO, Jung MH, Ock MS, Cha HJ. Elevated expression of thymosin β4, vascular endothelial growth factor (VEGF), and hypoxia inducible factor (HIF)-1alpha in early-stage cervical cancers. Pathol Oncol Res 2011;17(3):493–502.
   PubMed Web of Science ®Google Scholar
• Moon HS, Even-Ram S, Kleinman HK, Cha HJ. Zyxin is upregulated in the nucleus by thymosin β4 in SiHa cells. Exp Cell Res 2006;312(17):3425–3431.
   PubMed Web of Science ®Google Scholar
• Oh SY, Song JH, Gil JE, Kim JH, Yeom YI, Moon EY. ERK activation by thymosin-β4 (TB4) overexpression induces paclitaxel-resistance. Exp Cell Res 2006;312(9):1651–1657.
   PubMed Web of Science ®Google Scholar
• Oh JM, Ryoo IJ, Yang Y, Kim HS, Yang KH, Moon EY. Hypoxia-inducible transcription factor (HIF)-1 alpha stabilization by actin-sequestering protein, thymosin β4 (Tβ4) in Hela cervical tumor cells. Cancer Lett 2008;264(1):29–35.
   PubMed Web of Science ®Google Scholar
• Huang L, Zheng M, Zhou QM, Zhang MY, Jia WH, Yun JP, Wang HY. Identification of a gene-expression signature for predicting lymph node metastasis in patients with early stage cervical carcinoma. Cancer 2011;117(15):3363–3373.
   PubMed Web of Science ®Google Scholar
• Dhaese S, Jonckheere V, Goethals M, Waltregny D, Vandekerckhove J, Ampe C, Van Troys M. Functional and profiling studies prove that prostate cancer upregulated neuroblastoma thymosin β is the true human homologue of rat thymosin β15. FEBS Lett 2007;581(25):4809–4815.
   PubMed Web of Science ®Google Scholar
• Banyard J, Barrows C, Zetter BR. Differential regulation of human thymosin β15 isoforms by transforming growth factor β1. Genes Chromosomes Canc 2009;48(6):502–509.
   PubMed Web of Science ®Google Scholar
• Bao L, Loda M, Janmey PA, Stewart R, Anand-Apte B, Zetter BR. Thymosin β15: a novel regulator of tumor cell motility upregulated in metastatic prostate cancer. Nat Med 1996;2(12):1322–1328.
   PubMed Web of Science ®Google Scholar
• Banyard J, Hutchinson LM, Zetter BR. Thymosin β-NB is the human isoform of rat thymosin β15. Ann NY Acad Sci 2007;1112:286–296.
   PubMed Web of Science ®Google Scholar
• Chakravatri A, Zehr EM, Zietman AL, Shipley WU, Goggins WB, Finkelstein DM, Young RH, Chang EL, Wu CL. Thymosin β15 predicts for distant failure in patients with clinically localized prostate cancer-results from a pilot study. Urology 2000;55(5):635–638.
   PubMed Web of Science ®Google Scholar
• Iguchi K, Ito M, Usui S, Mizokami A, Namiki M, Hirano K. Downregulation of thymosin β4 expression by androgen in prostate cancer LNCaP cells. J Androl 2008;29(2):207–212.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Okada F, Fujii N, Tomita N, Ito S, Tazawa H, Aoyama T, Choi SK, Shibata T, Fujita H, Hosokawa M. Thymosin-β4 regulates motility and metastasis of malignant mouse fibrosarcoma cells. Am J Pathol 2002;160(3):869–882.
   PubMed Web of Science ®Google Scholar
• Santelli G, Califano D, Chiappetta G, Vento MT, Bartoli PC, Zullo F, Trapasso F, Viglietto G, Fusco A. Thymosin β10 gene overexpression is a general event in human carcinogenesis. Am J Pathol 1999;155(3):799–804.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Feurino LW, Zhai Q, Wang H, Fisher WE, Chen C, Yao Q, Li M. Thymosin β4 is overexpressed in human pancreatic cancer cells and stimulates proinflammatory cytokine secretion and JNK activation. Cancer Biol Ther 2008;7(3): 419–423.
   PubMed Web of Science ®Google Scholar
• Alldinger I, Dittert D, Peiper M, Fusco A, Chiappetta G, Staub E, Lohr M, Jesnowski R, Baretton G, Ockert D, Saeger HD, Grutzmann R, Pilarsky C. Gene expression analysis of pancreatic cell lines reveals genes overexpressed in pancreatic cancer. Pancreatology 2005;5(4–5):370–379.
   PubMed Web of Science ®Google Scholar
• Li M, Zhang Y, Zhai Q, Feurino LW, Fisher WE, Chen C, Yao Q. Thymosin β10 is aberrantly expressed in pancreatic cancer and induces JNK activation. Cancer Invest 2009;27(3):251–256.
   PubMed Web of Science ®Google Scholar
• Hall AK. Differential expression of thymosin genes in human tumors and in the developing human kidney. Int J Cancer 1991;48(5):672–677.
   PubMed Web of Science ®Google Scholar
• Hall AK. Amplification-independent overexpression of thymosin β10 mRNA in human renal cell carcinoma. Ren Fail 1994;16(2):243–254.
   PubMed Web of Science ®Google Scholar
• Wang AG, Yoon SY, Oh JH, Jeon YJ, Kim M, Kim JM, Byun SS, Yang JO, Kim JH, Kim DG, Yeom YI, Yoo HS, Kim YS, Kim NS. Identification of intrahepatic cholangiocarcinoma related genes by comparison with normal liver tissues using expressed sequence tags. Biochem Biophys Res Commun 2006;345(3):1022–1032.
   PubMed Web of Science ®Google Scholar
• Sardi I, Tintori V, Marchi C, Veltroni M, Lippi A, Tucci F, Tamburini A, Bernini G, Faulkner L. Molecular profiling of high-risk neuroblastoma by cDNA array. Int J Mol Med 2002;9(5):541–545.
   PubMed Web of Science ®Google Scholar
• Wang ZY, Zeng FQ, Zhu ZH, Jiang GS, Lv L, Wan F, Dong R, Xiao XY, Xing SA. Evaluation of thymosin β4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma. Urol Oncol 2012;30(2):167–176.
   PubMed Web of Science ®Google Scholar
• Akhter M, Kobayashi I, Kiyoshima T, Matsuo K, Yamaza H, Wada H, Honda JY, Ming X, Sakai H. Possible functional involvement of thymosin β4 in developing tooth germ of mouse lower first molar. Histochem Cell Biol 2005;124(3–4):207–213.
   PubMed Web of Science ®Google Scholar
• Cha HJ, Philp D, Lee SH, Moon HS, Kleinman HK, Nakamura T. Over-expression of thymosin β4 promotes abnormal tooth development and stimulation of hair growth. Int J Dev Biol 2010;54(1):135–140.
   PubMed Web of Science ®Google Scholar
• Barnaeva E, Nadezhda A, Hannappel E, Sjogren MH, Rojkind M. Thymosin β4 upregulates the expression of hepatocyte growth factor and downregulates the expression of PDGF-β receptor in human hepatic stellate cells. Ann NY Acad Sci 2007;1112:154–160.
   PubMed Web of Science ®Google Scholar
• Reyes-Gordillo K, Shah R, Popratiloff A, Fu S, Hindle A, Brody F, Rojkind M. Thymosin β4 (Tβ4) blunts PDGF-dependent phosphorylation and binding of AKT to actin in hepatic stellate cells. Am J Pathol 2011;178(5):2100–2108.
   PubMed Web of Science ®Google Scholar
• Leeanansaksiri W, DeSimone SK, Huff T, Hannappel E, Huff TF. Thymosin β4 and its N-terminal tetrapeptide, AcSDKP, inhibit proliferation, and induce dysplastic, non-apoptotic nuclei and degranulation of mast cells. Chem Biodivers 2004;1(7):1091–1100.
   PubMed Web of Science ®Google Scholar
• Leslie M. Mast cells show their might. Science 2007;317(5838):614–616.
   PubMed Web of Science ®Google Scholar
• Wyczolkowska J, Walczak-Drzewiecka A, Wagner W, Dastych J. Thymosin β4 and thymosin β4-derived peptides induce mast cell exocytosis. Peptides 2007;28(4):752–759.
   PubMed Web of Science ®Google Scholar
• Tokura Y, Nakayama Y, Fukada S, Nara N, Yamamoto H, Matsuda R, Hara T. Muscle injury-induced thymosin β4 acts as a chemoattractant for myoblasts. J Biochem 2011;149(1):43–48.
   PubMed Web of Science ®Google Scholar
• Silva WA, Jr, Covas DT, Panepucci RA, Proto-Siqueira R, Siufi JL, Zanette DL, Santos AR, Zago MA. The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells 2003;21(6):661–669.
   PubMed Web of Science ®Google Scholar